Hospital General Juan Cardona, La Coruña, Spain.
Metabolism. 2012 Nov;61(11):1495-511. doi: 10.1016/j.metabol.2012.07.007. Epub 2012 Aug 24.
Free ammonium ions are produced and consumed during cell metabolism. Glutamine synthetase utilizes free ammonium ions to produce glutamine in the cytosol whereas glutaminase and glutamate dehydrogenase generate free ammonium ions in the mitochondria from glutamine and glutamate, respectively. Ammonia and bicarbonate are condensed in the liver mitochondria to yield carbamoylphosphate initiating the urea cycle, the major mechanism of ammonium removal in humans. Healthy kidney produces ammonium which may be released into the systemic circulation or excreted into the urine depending predominantly on acid-base status, so that metabolic acidosis increases urinary ammonium excretion while metabolic alkalosis induces the opposite effect. Brain and skeletal muscle neither remove nor produce ammonium in normal conditions, but they are able to seize ammonium during hyperammonemia, releasing glutamine. Ammonia in gas phase has been detected in exhaled breath and skin, denoting that these organs may participate in nitrogen elimination. Ammonium homeostasis is profoundly altered in liver failure resulting in hyperammonemia due to the deficient ammonium clearance by the diseased liver and to the development of portal collateral circulation that diverts portal blood with high ammonium content to the systemic blood stream. Although blood ammonium concentration is usually elevated in liver disease, a substantial role of ammonium causing hepatic encephalopathy has not been demonstrated in human clinical studies. Hyperammonemia is also produced in urea cycle disorders and other situations leading to either defective ammonium removal or overproduction of ammonium that overcomes liver clearance capacity. Most diseases resulting in hyperammonemia and cerebral edema are preceded by hyperventilation and respiratory alkalosis of unclear origin that may be caused by the intracellular acidosis occurring in these conditions.
游离氨离子在细胞代谢过程中产生和消耗。谷氨酰胺合成酶利用游离氨离子在细胞质中产生谷氨酰胺,而谷氨酰胺酶和谷氨酸脱氢酶分别从谷氨酰胺和谷氨酸中产生游离氨离子。氨和碳酸氢盐在肝线粒体中缩合生成氨甲酰磷酸,启动尿素循环,这是人体中铵去除的主要机制。健康的肾脏会产生铵,根据酸碱状态,铵可能会释放到全身循环或排泄到尿液中,因此代谢性酸中毒会增加尿铵排泄,而代谢性碱中毒则会产生相反的效果。在正常情况下,大脑和骨骼肌既不去除也不产生铵,但在高氨血症时,它们能够摄取铵,释放出谷氨酰胺。气相中的氨已在呼出的气体和皮肤中检测到,这表明这些器官可能参与氮的排泄。肝脏衰竭时,铵稳态会发生深刻改变,导致高氨血症,这是由于患病肝脏清除铵的能力不足以及门脉侧支循环的发展,将含有高浓度铵的门脉血液分流到全身血流中所致。尽管在肝脏疾病中通常会升高血液中的铵浓度,但在人体临床研究中,并未证明铵在肝性脑病中起重要作用。尿素循环障碍和其他导致铵去除缺陷或铵过度产生超过肝脏清除能力的情况也会导致高氨血症。导致高氨血症和脑水肿的大多数疾病之前都伴有不明原因的过度通气和呼吸性碱中毒,这可能是由于这些情况下细胞内酸中毒引起的。